M F Marmor

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Simulating vision with and without macular disease
    David J Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Dr, Room A 157, Stanford, CA 94305 5308, USA
    Arch Ophthalmol 128:117-25. 2010
  2. ncbi Escher and the ophthalmologist
    Michael F Marmor
    Stanford University School of Medicine, Stanford, California 94305 5308, USA
    Surv Ophthalmol 48:356-61. 2003
  3. ncbi Standard for clinical electroretinography (2004 update)
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305-5308, USA
    Doc Ophthalmol 108:107-14. 2004
  4. ncbi Comparison of screening procedures in hydroxychloroquine toxicity
    Michael F Marmor
    Stanford University School of Medicine, Byers Eye Institute at Stanford, 2452 Watson Ct, Palo Alto, CA 94303 5353
    Arch Ophthalmol 130:461-9. 2012
  5. ncbi Differential gene expression in anatomical compartments of the human eye
    Jennifer J Diehn
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Genome Biol 6:R74. 2005
  6. ncbi Mechanisms of fluid accumulation in retinal edema
    M F Marmor
    Stanford University, Calif, USA
    Doc Ophthalmol 97:239-49. 1999
  7. ncbi Recognition of small stimulus screen masks using the multifocal ERG
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, CA 94305 5308, USA
    Doc Ophthalmol 104:277-86. 2002
  8. ncbi Alcohol- and light-induced electro-oculographic responses: variability and clinical utility
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Drive, Boswell A157, CA 94305 5308, USA
    Doc Ophthalmol 110:227-36. 2005
  9. ncbi Clinical S-cone ERG recording with a commercial hand-held full-field stimulator
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 109:101-7. 2004
  10. ncbi Guidelines for basic multifocal electroretinography (mfERG)
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA
    Doc Ophthalmol 106:105-15. 2003

Collaborators

Detail Information

Publications55

  1. ncbi Simulating vision with and without macular disease
    David J Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Dr, Room A 157, Stanford, CA 94305 5308, USA
    Arch Ophthalmol 128:117-25. 2010
    ..They also dramatically show the impact of macular disease (with scotomas and visual distortion), as there is no surrounding region of clarity. We hope these images will be instructive to both physicians and patients...
  2. ncbi Escher and the ophthalmologist
    Michael F Marmor
    Stanford University School of Medicine, Stanford, California 94305 5308, USA
    Surv Ophthalmol 48:356-61. 2003
    ..A correspondence began that extended for almost a decade and altered Escher's concept of his own work. It is an intriguing footnote to the career of this extraordinary artist...
  3. ncbi Standard for clinical electroretinography (2004 update)
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305-5308, USA
    Doc Ophthalmol 108:107-14. 2004
  4. ncbi Comparison of screening procedures in hydroxychloroquine toxicity
    Michael F Marmor
    Stanford University School of Medicine, Byers Eye Institute at Stanford, 2452 Watson Ct, Palo Alto, CA 94303 5353
    Arch Ophthalmol 130:461-9. 2012
    ..To compare different screening procedures for hydroxychloroquine sulfate (Plaquenil) toxicity at different stages of damage...
  5. ncbi Differential gene expression in anatomical compartments of the human eye
    Jennifer J Diehn
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Genome Biol 6:R74. 2005
    ..We set out to systematically characterize the global gene expression patterns that specify the distinctive characteristics of the various eye compartments...
  6. ncbi Mechanisms of fluid accumulation in retinal edema
    M F Marmor
    Stanford University, Calif, USA
    Doc Ophthalmol 97:239-49. 1999
    ..Consideration of the pathophysiology of retinal edema may aid in the development of better strategies for managing retinal edema...
  7. ncbi Recognition of small stimulus screen masks using the multifocal ERG
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, CA 94305 5308, USA
    Doc Ophthalmol 104:277-86. 2002
    ..With coarser stimulus arrays (e.g. 103 or 61 hexagons), the effect of a small scotoma depends on its location relative to the stimulus cells. These issues should be considered when selecting mfERG recording conditions...
  8. ncbi Alcohol- and light-induced electro-oculographic responses: variability and clinical utility
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Drive, Boswell A157, CA 94305 5308, USA
    Doc Ophthalmol 110:227-36. 2005
    ..The alcohol-induced EOG has too broad a range of responses to be useful clinically for the one-time evaluation of individual patients. We have similar concerns regarding clinical applications of the standard light-induced EOG...
  9. ncbi Clinical S-cone ERG recording with a commercial hand-held full-field stimulator
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 109:101-7. 2004
    ..In general, the S-cone responses followed the standard cone ERG responses in disease...
  10. ncbi Guidelines for basic multifocal electroretinography (mfERG)
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA
    Doc Ophthalmol 106:105-15. 2003
  11. ncbi The Stanford years
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, Room A-157 Boswell Bldg, Stanford, CA 94305-5308, USA
    Exp Eye Res 78:xxv-xxvi. 2004
  12. ncbi Comparison of conventional ERG parameters and high-intensity A-wave analysis in a clinical setting
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 106:281-7. 2003
    ....
  13. ncbi Albipunctate retinopathy with cone dysfunction and no abnormality in the RDH5 or RLBP1 genes
    Michael F Marmor
    Department of Ophthalmology, A-157, Stanford University School of Medicine, Stanford, CA 94305-5308, USA
    Retina 23:543-6. 2003
  14. ncbi Ophthalmology and art: simulation of Monet's cataracts and Degas' retinal disease
    Michael F Marmor
    Department of Ophthalmology, Stanford University, Stanford, CA 94305-5308, USA
    Arch Ophthalmol 124:1764-9. 2006
  15. ncbi The dilemma of the late-onset "dystrophy"
    Michael F Marmor
    Department of Ophthalmology, A 157, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 114:107-9. 2007
    ..This patient had anti-enolase antibodies, and demonstrates the importance of auto-immune retinopathy as a potential cause of late-onset retinal "dystrophy."..
  16. ncbi A teenager with nightblindness and cystic maculopathy: enhanced S cone syndrome (Goldmann-Favre syndrome)
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 113:213-5. 2006
    ..The case below (enhanced S cone syndrome) is a good example of this, and demonstrates the diagnostic importance of clinical electrophysiology...
  17. ncbi Pattern dystrophy of the retinal pigment epithelium and geographic atrophy of the macula
    M F Marmor
    Department of Ophthalmology, Stanford University Medical Center, CA 94305 5308, USA
    Am J Ophthalmol 122:382-92. 1996
    ..We sought to evaluate the evolution of symptoms, fundus changes, and physiologic findings by re-examining a family with pattern dystrophy after 20 years...
  18. ncbi Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities
    M F Marmor
    Department of Ophthalmology, Stanford University Medical Center, Calif 94305 5308, USA
    Arch Ophthalmol 117:184-8. 1999
    ..To assess retinal function topographically in the posterior pole of affected and fellow eyes with central serous chorioretinopathy...
  19. ncbi The training of George K. Kambara, MD
    M F Marmor
    Department of Ophthalmology, Stanford University, Calif, USA
    Arch Ophthalmol 117:1227-35. 1999
    ..His story shows a triumph of the spirit, but is also a reminder of dark times that should not be forgotten...
  20. ncbi Fluorescein angiography: insight and serendipity a half century ago
    Michael F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, CA, USA
    Arch Ophthalmol 129:943-8. 2011
    ..The first article was rejected by the ophthalmology literature, but several clinics heard about it and soon documented the enormous diagnostic value of the procedure...
  21. ncbi Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana
    Michael F Marmor
    Department of Ophthalmology, Stanford University Medical Center, 300 Pasteur Dr, Room A 157, Stanford, CA 94305 5308, USA
    Arch Ophthalmol 126:907-13. 2008
    ..To elucidate the visual significance of the foveal pit by measuring foveal architecture and function and to reassess use of the term foveal hypoplasia (as visual acuity can vary among patients who lack a pit)...
  22. ncbi ISCEV standard for clinical electro-oculography (2010 update)
    Michael F Marmor
    Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, CA, USA
    Doc Ophthalmol 122:1-7. 2011
    ..It is intended to promote consistent quality of testing and reporting within and between clinical centers...
  23. ncbi The dilemma of color deficiency and art
    M F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA
    Surv Ophthalmol 45:407-15. 2001
    ..It is instructive to know how proven color deficiency has influenced an artist's style. When medical information is unavailable, the best advice for the diagnostically-inclined observer is just to enjoy the art...
  24. ncbi ISCEV Standard for full-field clinical electroretinography (2008 update)
    M F Marmor
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA
    Doc Ophthalmol 118:69-77. 2009
    ..0 oscillatory potentials; (4) Light-adapted 3.0 ERG (cone response); (5) Light-adapted 3.0 flicker (30 Hz flicker). An additional Dark-adapted 10.0 ERG or Dark-adapted 30.0 ERG response is recommended...
  25. ncbi Total rod ERG suppression with high dose compassionate Fenretinide usage
    Michael F Marmor
    Department of Ophthalmology, Room A 157, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA, 94305 5308, USA
    Doc Ophthalmol 117:257-61. 2008
    ..It is intriguing that cone function and access to vitamin A seems largely independent of Fenretinide effects on retinol availability...
  26. ncbi Effects on retinal adhesive force in vivo of metabolically active agents in the subretinal space
    M Kita
    Department of Ophthalmology, Stanford University School of Medicine, California 94305
    Invest Ophthalmol Vis Sci 33:1883-7. 1992
    ..Furosemide and amiloride in the subretinal space caused slight slowing of subretinal fluid absorption; acetazolamide had no effect. These data support the concept that metabolic factors contribute to retinal adhesion in vivo...
  27. ncbi Dextromethorphan protects retina against ischemic injury in vivo
    Y H Yoon
    Department of Ophthalmology, Stanford University School of Medicine, CA 94305
    Arch Ophthalmol 107:409-11. 1989
    ..Dextromethorphan may prove to be useful clinically in the management of retinal ischemic disease...
  28. ncbi Alcohol- and light-induced electro-oculographic responses in age-related macular degeneration & central serous chorioretinopathy. alcohol- and light-induced EOG responses in ARMD & CSC
    Kathy H C Wu
    Department of Ophthalmology, Stanford University Medical Center, CA 94305-5308, USA
    Doc Ophthalmol 110:237-46. 2005
    ..These data suggest that neither the alcohol- nor the light-induced EOG is a sensitive indicator of these diseases...
  29. ncbi Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness
    T J Wolfensberger
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, USA
    Graefes Arch Clin Exp Ophthalmol 238:76-80. 2000
    ..This study investigates how benzolamide, a carbonic anhydrase inhibitor which does not readily penetrate cell membranes, modulates retinal pigment epithelium functions relative to acetazolamide, which diffuses into the cytosol...
  30. ncbi Rod and cone visual cycle consequences of a null mutation in the 11-cis-retinol dehydrogenase gene in man
    A V Cideciyan
    Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia 19104, USA
    Vis Neurosci 17:667-78. 2000
    ..Pathways in addition to 11-cis-RDH likely provide 11-cis-retinal for rods and cones and can maintain normal kinetics of visual recovery but only under certain constraints and less efficiently for cone than rod function...
  31. ncbi Revisiting talc retinopathy
    Christopher I Zoumalan
    Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Arch Ophthalmol 125:988. 2007
  32. ncbi Intrasession variability of the full-field ERG
    Grant D Hochstein
    Program in Human Biology, Stanford University, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 115:77-83. 2007
    ..1) To document variability of the full-field ERG within single recording sessions under ISCEV standards. (2) To identify clinical factors contributing to the observed variability...
  33. ncbi Effects of the pulsed electron avalanche knife on retinal tissue
    Daniel V Palanker
    W W Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305 4085, USA
    Arch Ophthalmol 120:636-40. 2002
    ..To evaluate the precision of retinal tissue dissection by the pulsed electron avalanche knife (PEAK) and to assess possible toxic effects from this device...
  34. ncbi The ophthalmic trials of G. H. A. Hansen
    Michael F Marmor
    Stanford University School of Medicine, Stanford, CA 94305-5308, USA
    Surv Ophthalmol 47:275-87. 2002
    ..He was convicted, and relieved of his post as staff physician, but he was allowed to retain an appointment as Chief Medical Officer of Health for Leprosy, in which capacity he worked for the rest of his life...
  35. ncbi Effects of pre-adaptation conditions and ambient room lighting on the multifocal ERG
    Aimee V Chappelow
    Stanford University, California, USA
    Doc Ophthalmol 105:23-31. 2002
    ..The most stable mfERG recording condition appears to be a fully lighted room (1.6 log cd/m2)...
  36. ncbi Precision and safety of the pulsed electron avalanche knife in vitreoretinal surgery
    Jason M Miller
    Department of Ophthalmology, School of Medicine and W. W. Hansen Experimental Physics Laboratory, Stanford University, Calif 94305, USA
    Arch Ophthalmol 121:871-7. 2003
    ....
  37. ncbi Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram
    J K Luu
    Medical Center, Stanford University, Stanford, CA 94305, USA
    Am J Ophthalmol 132:388-94. 2001
    ..However, the affected electroretinogram and multifocal electroretinogram parameters still remained within normal limits...
  38. ncbi Pulsed electron avalanche knife (PEAK) for intraocular surgery
    D V Palanker
    Department of Ophthalmology, School of Medicine, Stanford University, Stanford, California, USA
    Invest Ophthalmol Vis Sci 42:2673-8. 2001
    ..The use of highly localized electric fields rather than laser light as the means of tissue dissection was investigated...
  39. ncbi Localized neurotransmitter release for use in a prototype retinal interface
    Mark C Peterman
    Department of Applied Physics, E. L. Ginzton Laboratory, Stanford University School of Medicine, Stanford, California 94305, USA
    Invest Ophthalmol Vis Sci 44:3144-9. 2003
    ..Although this is only a proof of concept of neurotransmitter stimulation for a retinal prosthesis, it is a significant first step toward mimicking neurotransmitter release during synaptic transmission...
  40. ncbi ERG findings in patients using hydroxychloroquine
    Radouil T Tzekov
    Department of Ophthalmology, Stanford University Medical Center, Stanford, CA 94305-5308, USA
    Doc Ophthalmol 108:87-97. 2004
    ..Further work is needed in order to separate pharmacological actions of the drug, retinopathy from the systemic disease, and potential toxic effects...
  41. ncbi Retinal evaluation of patients on chronic amiodarone therapy
    Saad Shaikh
    Department of Ophthalmology, Stanford University Medical Center, Stanford, California, USA
    Retina 23:354-9. 2003
    ..To determine whether retinal electrophysiologic changes can be detected and correlated with funduscopic findings in patients with the long-term use of amiodarone...
  42. ncbi Microcontact printing on human tissue for retinal cell transplantation
    Christina J Lee
    Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA
    Arch Ophthalmol 120:1714-8. 2002
    ....
  43. ncbi The lens-coating agent and the electroretinogram
    Alexandra Serrato
    Department of Ophthalmology, Stanford University Medical Center, Stanford, CA 94305-5308, USA
    Doc Ophthalmol 106:225-30. 2003
    ..ERG laboratories should be consistent in the use of coating agents, and be aware that any change in solution might alter normative values by a modest percentage...
  44. ncbi Nyctalopia or not?
    Michael F Marmor
    Stanford, California
    Ophthalmology 109:1763; discussion 1764. 2002
  45. ncbi Are circadian variations in the electroretinogram evident on routine testing?
    Mira Marcus
    Department of Ophthalmology, Stanford University Medical Center, Stanford, CA 94305-5308, USA
    Doc Ophthalmol 108:165-9. 2004
    ..We suggest that the time of day be noted on clinical recordings, in case this information becomes relevant for a particular patient...
  46. ncbi ERG evaluation of daily, high-dose sildenafil usage
    Christopher I Zoumalan
    Department of Ophthalmology, Stanford University School of Medicine, Boswell Building, Stanford, CA 94305 5308, USA
    Doc Ophthalmol 118:225-31. 2009
    ..The purpose of our study is to investigate possible ERG changes in subjects using large doses of sildenafil on a chronic daily basis...
  47. ncbi Retinal evaluation after 810 nm Dioderm laser removal of eyelashes
    Randal T H Pham
    Department of Ophthalmology, Stanford University, California, USA
    Dermatol Surg 28:836-40. 2002
    ....
  48. ncbi Directed retinal nerve cell growth for use in a retinal prosthesis interface
    Theodore Leng
    Ophthalmic Tissue Engineering Laboratory, Department of Ophthalmology, Stanford University School of Medicine, Stanford, California 94305, USA
    Invest Ophthalmol Vis Sci 45:4132-7. 2004
    ..This may allow discrete populations of retinal neurons to be addressed so that physiologic retinal processing of visual information can be achieved...
  49. ncbi Hydroxychloroquine at the recommended dose (< or = 6.5 mg/kg/day) is safe for the retina in patients with rheumatoid arthritis and systemic lupus erythematosus
    Michael F Marmor
    Stanford University School of Medicine, California 94305-5308, USA
    Clin Exp Rheumatol 22:143-4. 2004
  50. ncbi The dilemma of hydroxychloroquine screening: new information from the multifocal ERG
    Michael F Marmor
    Am J Ophthalmol 140:894-5. 2005
  51. ncbi Visual evoked potentials standard (2004)
    J Vernon Odom
    West Virginia University Eye Institute, Morgantown, WV 26506-9193, USA
    Doc Ophthalmol 108:115-23. 2004
  52. ncbi Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology
    Michael F Marmor
    Ophthalmology 109:1377-82. 2002
  53. ncbi "Do you, doctor, take the mfERG.for better or for worse?"
    Michael F Marmor
    Graefes Arch Clin Exp Ophthalmol 240:241-3. 2002
  54. ncbi Was Rembrandt stereoblind?
    Michael F Marmor
    N Engl J Med 352:631-2; author reply 631-2. 2005
  55. ncbi New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy
    Michael F Marmor
    Arthritis Rheum 48:1764. 2003